Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Lissy de Ridder

17PUBLICATIONS
56CO-AUTHORS
Infant and child healthImmunogenetics (incl. genetic immunology)Gene and molecular therapyAdolescent healthRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

Sort by Publication Date:
|Jul 18, 2025
Management of paediatric ulcerative colitis, part 1: Ambulatory care-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation.

Eytan Wine, Marina Aloi, Stephanie Van Biervliet

|Jun 18, 2025
Management of paediatric ulcerative colitis, part 2: Acute severe colitis-An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organization.

Amit Assa, Marina Aloi, Stephanie Van Biervliet

|Oct 30, 2024
Considerations in Paediatric and Adolescent Inflammatory Bowel Disease.

Stephanie A Vuijk, Anouk E Camman, Lissy de Ridder

|Oct 05, 2024
Editorial: Distinct Challenges of Paediatric From Adult-Onset Inflammatory Bowel Disease, Implications of Aggressive Disease Phenotypes and Early Biologic Therapy in Children.

Alessandro Molinaro, Lissy de Ridder

|May 22, 2024
Editorial: Infliximab induction therapy in paediatric Crohn's disease - A cost-effective strategy? Authors' reply.

Stephanie A Vuijk, Lissy de Ridder

|Apr 22, 2024
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's disease.

Stephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven

Pageof 3

Frequent Collaborators

5 joint publications

Richard K Russell

5 joint publications

Stephanie A Vuijk

3 joint publications

Marina Aloi

3 joint publications

Nicholas M Croft

3 joint publications

Jiri Bronsky

3 joint publications

Patrick van Rheenen

3 joint publications

Dror S Shouval

3 joint publications

David C Wilson

2 joint publications

Eytan Wine

2 joint publications

Amit Assa

Frequent Collaborators

5 joint publications

Richard K Russell

5 joint publications

Stephanie A Vuijk

3 joint publications

Marina Aloi

3 joint publications

Nicholas M Croft

Top Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on : May 16, 2025

320
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on : Mar 01, 2022

3.8K
See more related videos

Top Related Videos

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on : May 16, 2025

320
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on : Mar 01, 2022

3.8K
See more related videos